230 related articles for article (PubMed ID: 25254414)
1. Evaluation of QMS everolimus assay using Indiko analyzer: comparison with an ultra-performance liquid chromatography-tandem mass spectrometry method.
Buthiau D; Bargnoux AS; Badiou S; Sutra T; Dupuy AM; Pageaux GP; Mourad G; Cristol JP
Ther Drug Monit; 2015 Apr; 37(2):275-8. PubMed ID: 25254414
[TBL] [Abstract][Full Text] [Related]
2. Analytical performance of QMS everolimus assay on ortho Vitros 5,1 FS fusion analyzer: measuring everolimus trough levels for solid organ transplant recipients.
Shu I; Wright AM; Chandler WL; Bernard DW; Wang P
Ther Drug Monit; 2014 Apr; 36(2):264-8. PubMed ID: 24232125
[TBL] [Abstract][Full Text] [Related]
3. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the New Siemens Tacrolimus Assay on the Dimension EXL Integrated Chemistry System Analyzer: Comparison With an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method.
Bargnoux AS; Sutra T; Badiou S; Kuster N; Dupuy AM; Mourad G; Pageaux GP; Le Quintrec M; Cristol JP
Ther Drug Monit; 2016 Dec; 38(6):808-812. PubMed ID: 27494947
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of QMS everolimus assay using Hitachi 917 Analyzer: comparison with liquid chromatography/mass spectrometry.
Dasgupta A; Davis B; Chow L
Ther Drug Monit; 2011 Apr; 33(2):149-54. PubMed ID: 21266941
[TBL] [Abstract][Full Text] [Related]
6. Everolimus TDM using Thermo Fisher QMS immunoassay on Indiko, Beckman DxC, AU680, and AU5800 analyzers.
Wong SH; Johnson-Davis KL; Garrison K; Rankin JD; Muhammad CS
Clin Biochem; 2017 May; 50(7-8):425-430. PubMed ID: 27988326
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the interchangeability between the new fully-automated affinity chrome-mediated immunoassay (ACMIA) and the Quantitative Microsphere System (QMS) with a CE-IVD-certified LC-MS/MS assay for therapeutic drug monitoring of everolimus after solid organ transplantation.
Ialongo C; D'alessandro A; Sapio M; Angeloni A; Porzio O
Clin Chem Lab Med; 2023 Jan; 61(2):245-250. PubMed ID: 36330751
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Performance of Laboratory-Developed Liquid Chromatography-Tandem Mass Spectrometry Tests and a Food and Drug Administration-Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus.
Schniedewind B; Meyer EJ; Christians U
Ther Drug Monit; 2020 Jun; 42(3):421-426. PubMed ID: 32427781
[TBL] [Abstract][Full Text] [Related]
10. Analytical Performance of the New Siemens Affinity Chrome-Mediated Immunoassay Everolimus Assay and Its Interchangeability With the Thermo Quantitative Microsphere System for Routine Therapeutic Drug Monitoring of Patients After Solid Organ Transplantation.
Ialongo C; Sapio M; Angeloni A
Ther Drug Monit; 2023 Apr; 45(2):217-222. PubMed ID: 36920504
[TBL] [Abstract][Full Text] [Related]
11. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
Verstraete AG; Rigo-Bonnin R; Wallemacq P; Vogeser M; Schuetzenmeister A; Schmiedel C; Shipkova M
Ther Drug Monit; 2018 Feb; 40(1):59-68. PubMed ID: 29210975
[TBL] [Abstract][Full Text] [Related]
13. Two rapid ultra performance liquid chromatography/tandem mass spectrometry (UPLC/MS/MS) methods with common sample pretreatment for therapeutic drug monitoring of immunosuppressants compared to immunoassay.
Tszyrsznic W; Borowiec A; Pawlowska E; Jazwiec R; Zochowska D; Bartlomiejczyk I; Zegarska J; Paczek L; Dadlez M
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 928():9-15. PubMed ID: 23584041
[TBL] [Abstract][Full Text] [Related]
14. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
15. Latex-enhanced turbidimetric immunoassay for everolimus in whole blood using the Nanopia TDM everolimus assay with the JCA-BM6010 automatic analyzer.
Mori K; Kimura S; Matsui M; Suehisa E; Hidaka Y; Fukushima N
Ther Drug Monit; 2014 Oct; 36(5):677-80. PubMed ID: 25222856
[TBL] [Abstract][Full Text] [Related]
16. Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.
Schniedewind B; Niederlechner S; Galinkin JL; Johnson-Davis KL; Christians U; Meyer EJ
Ther Drug Monit; 2015 Jun; 37(3):296-303. PubMed ID: 25970506
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method.
Johnson-Davis KL; De S; Jimenez E; McMillin GA; De BK
Ther Drug Monit; 2011 Aug; 33(4):453-9. PubMed ID: 21743377
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method.
Dasgupta A; Tso G; Chow L
Clin Biochem; 2013 May; 46(7-8):685-7. PubMed ID: 23219740
[TBL] [Abstract][Full Text] [Related]
19. A Comparison of the Immunochemical Methods, PETINIA and EMIT, With That of HPLC-UV for the Routine Monitoring of Mycophenolic Acid in Heart Transplant Patients.
Kunicki PK; Pawiński T; Boczek A; Waś J; Bodnar-Broniarczyk M
Ther Drug Monit; 2015 Jun; 37(3):311-8. PubMed ID: 25380305
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
McMillin GA; Johnson-Davis K; Dasgupta A
Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
